Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples

Purpose Prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRP-R) are expressed in prostate cancer and can be targeted with radiolabeled inhibitors and antagonists. Their performances for the initial characterization of prostatic tumors have been barely evaluated but n...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	EJNMMI research Ročník 9; číslo 1; s. 1 - 7
Hlavní autori:	Schollhammer, Romain, De Clermont Gallerande, Henri, Yacoub, Mokrane, Quintyn Ranty, Marie-Laure, Barthe, Nicole, Vimont, Delphine, Hindié, Elif, Fernandez, Philippe, Morgat, Clément
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Berlin/Heidelberg Springer Berlin Heidelberg 03.06.2019 Springer Nature B.V SpringerOpen
Predmet:	Antigens Binding Cancer surgery Cardiac Imaging GRP-R Histology Imaging Inhibitors Medicine Medicine & Public Health Metastasis Nuclear Medicine Oncology Original Research Orthopedics Prostate cancer PSMA Radiology Tracers Tumors GRP-R Prostate cancer PSMA
ISSN:	2191-219X, 2191-219X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!